| Fcγ receptors and immunomodulatory antibodies in cancer F Galvez-Cancino, AP Simpson, C Costoya, I Matos, D Qian, KS Peggs, ... Nature Reviews Cancer 24 (1), 51-71, 2024 | 29 | 2024 |
| FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms AP Simpson, A Roghanian, RJ Oldham, HTC Chan, CA Penfold, HJ Kim, ... Cell reports 40 (3), 2022 | 16 | 2022 |
| Oligomeric Aβ1-42 Induces an AMD-Like Phenotype and Accumulates in Lysosomes to Impair RPE Function SA Lynn, DA Johnston, JA Scott, R Munday, RS Desai, E Keeling, ... Cells 10 (2), 413, 2021 | 15 | 2021 |
| Phenotypic Characterization of Liver Sinusoidal Endothelial Cells on the Human Liver-Chip for Potential in vitro Therapeutic Antibody Pharmacology Applications PL Candarlioglu, S Jadalannagari, J Chaff, J Velez, SR Joshipura, ... bioRxiv, 2022.03. 04.482954, 2022 | 1 | 2022 |
| Immunotherapy drug target identification using machine learning and patient-derived tumour explant validation K Litchfield, M Augustine, NR Nene, H Fu, C Pinder, L Ligammari, ... | | 2024 |
| The contribution of the Fc RIIB immunoreceptor tyrosine-based inhibitory motif (ITIM) to the modulation of antibody immunotherapy AP Simpson University of Southampton, 2022 | | 2022 |
